Site #213 — Edinburg, Texas

Site #213 is a clinical research site located in Edinburg, Texas, United States 78539.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Site #213 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Nonalcoholic Steatohepatitis (NASH), Metabolic Dysfunction-associated Steatohepatitis (MASH).

Sponsors: Corcept Therapeutics.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site #213?

Site #213 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site #213 conducted?

Site #213 has 1 clinical trials on record, with 1 currently active. Their work covers Nonalcoholic Steatohepatitis (NASH), Metabolic Dysfunction-associated Steatohepatitis (MASH).

Is Site #213 accredited by Crixeo Health?

Site #213 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site #213?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.